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for Percutaneous Transluminal Septal
Myocardial Ablation in a Case of
Hypertrophic Obstructive Cardiomyopathy
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Yoshitake Yamada, MD, PHD,y Takashi Kawakami, MD,* Hideaki Kanazawa, MD, PHD,* Kentaro Hayashida, MD, PHD,*
Shinsuke Yuasa, MD, PHD,* Mitsushige Murata, MD, PHD,* Masahiro Jinzaki, MD, PHD,y Keiichi Fukuda, MD, PHD*A 57-year-old woman with known hypertrophicobstructive cardiomyopathy (HOCM) pre-sented with dyspnea and fatigue, consistent
with New York Heart Association (NYHA) functional
class III heart failure. The patient had previously
undergone percutaneous transluminal myocardial
ablation (PTSMA) twice at another hospital. Echocar-
diography revealed a “protruding myocardium,” sys-
tolic anterior motion of the mitral valve, and mild
mitral regurgitation (Figures 1A and 1B, Online
Videos 1 and 2). The “protruding myocardium”
adjoined the basal and mid-portion of the ventricular
myocardium that had been previously ablated. At
rest, the left ventricular outﬂow tract (LVOT)
gradient was 109 mm Hg. Comparison of the coro-
nary angiography that we performed with that per-
formed previously at another hospital conﬁrmed
that 1 of the 2 proximal septal branches could not
be used in PTSMA because the guidewire could
not be passed. The patient declined open surgery;
therefore, PTSMA was performed. Selective alcoholFrom the *Department of Cardiology, Keio University School of Medicine,
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the identiﬁed target vessels guided by real-time
2-dimensional echocardiography to the enhanced
saturation of each vascular bed (Figure 1C). The
post-procedural LVOT gradient was 7 mm Hg. Three
months later, her symptoms improved to NYHA func-
tional class I, and echocardiography revealed the
disappearance of the “protruding myocardium”
(Figure 1D, Online Video 3). Target vessel selection is
the most important step in PTSMA (1). Misidentiﬁca-
tion of the correct target vessel is a potential cause
of PTSMA failure. In addition, the guidewire can occa-
sionally fail to pass due to technical difﬁculties
despite correct identiﬁcation of the target septal
branches. Our case highlights the importance of target
vessel selection and complete myocardial ablation.
REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Yuichiro Maekawa, Department of Cardiology, Keio Uni-
versitySchoolofMedicine,Shinanomachi 35,Shinjuku-ku,
Tokyo 160-8582, Japan. E-mail: ymaekawa@a5.keio.jp.Tokyo, Japan; and the yDepartment of Diagnostic
ve reported that they have no relationships relevant
FIGURE 1 Transthoracic Echocardiographic Images and Coronary Angiogram
Two-dimensional (A, Online Video 1) and color Doppler (B, Online Video 2) images of the parasternal long-axis view demonstrating systolic
anterior motion of the mitral valve, mild mitral regurgitation, and a “protruding myocardium” (white arrow). (C) Coronary angiogram of the
right anterior oblique cranial projection showing the ﬁrst septal branch of the identiﬁed target vessels (white arrows). (D, Online Video 3) Two-
dimensional image of the parasternal long-axis view taken 3 months after percutaneous transluminal myocardial ablation demonstrating the
disappearance of the ablated “protruding myocardium.” Ao ¼ aorta; LA ¼ left atrium; LV ¼ left ventricle.
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